Pricing

TCR2 Therapeutics Inc (TCRR)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Garry E. Menzel
Employees:
140
100 BINNEY STREET, CAMBRIDGE, MA, 02142
617-949-5200
TCR2 Therapeutics Inc. focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. Lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC) and ovarian cancer.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available